Cancer Treatment Today

Both Halaven and Exjeva are new drugs that were recently approved.   HALAVEN( eribubilin) is indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting. This was based on an open-label, randomized, multicenter trial of

Breast cancer patients often suffer menopausal symptoms, which include vaginal dryness. This distressing symptom is often treated with topical estrogen or progesterone creams; however, there remains a concern about absorption of estrogen into the body and its effect on breast cancer. Many such patients are already on tavoxifen. In a group that is treated with tamoxifen, it would appear that most systemic effect would be negated by the tamoxifen's